Acutus Medical, a company headquartered in Carlsbad, California, won FDA clearance for its AcQMap High Resolution Imaging and Mapping System, as well as the accompanying AcQMap 3D Imaging and Mapping Catheter.
The catheter uses ultrasound and more traditional electrical tissue conduction mapping to create a unique live view inside the heart that combines the physical mechanics of the organ with its electrical activity.
This should be particularly useful during cardiac ablation procedures when monitoring the heart’s response to treatment.
“We are extremely excited to have participated in the early clinical work and are now using the technology as part of a patient-specific strategy to assess and treat complex arrhythmias,” in a statement said Dr. Tom Wong, from the Royal Brompton Hospital in London, England. “The AcQMap System is able to provide global dipole density mapping of irregular and chaotic activation in the atrial chambers, whereas conventional sequential mapping may struggle to provide us with the information that is required. In the cases we have performed thus far, real-time mapping of complex arrhythmias has allowed us to focus on areas of interest and terminate the arrhythmia using ablation therapy. We can now offer individualized, tailored therapy, and are one step closer to identifying the mechanisms of complex arrhythmias.”
Check out this example mapping created by the AcQMap system:
Link: Acutus Medical…
Via: Acutus…
